CHIOMA UMELO: Open Payments
NPI 1114634763 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 7 payments from 2 companies in 2025. Trend: 2023 $19 · 2024 $244 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $379 |
| ACADIA Pharmaceuticals Inc | 1 | $82 |
Products named: INGREZZA, NUPLAZID.
Industry payments across CT — which companies pay providers there.
